Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 9.85
-0.02 (-0.20%)
Jan 23, 2026, 3:00 PM CST
SHA:603229 Market Cap
SHA:603229 has a market cap or net worth of 8.18 billion as of January 22, 2026. Its market cap has increased by 9.52% in one year.
Market Cap
8.18B
Enterprise Value
7.42B
Revenue
751.12M
Ranking
n/a
PE Ratio
44.58
Stock Price
9.85
Market Cap Chart
Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 8.18B, an increase of 354.18%. That is a compound annual growth rate of 18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 8.18B | -0.50% |
| Dec 31, 2025 | 8.22B | -0.94% |
| Dec 31, 2024 | 8.29B | 5.87% |
| Dec 29, 2023 | 7.83B | -18.09% |
| Dec 30, 2022 | 9.56B | -8.49% |
| Dec 31, 2021 | 10.45B | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 9.50B |
| Sino Biological,Inc. | 9.45B |
| Jiangxi Fushine Pharmaceutical | 9.08B |
| Daan Gene | 8.86B |
| Nanjing Vazyme Biotech | 8.56B |
| Shanghai Medicilon | 8.28B |
| Wuhan Keqian Biology Co.,Ltd | 7.68B |
| Jiangsu Aidea Pharmaceutical Group | 7.65B |